Kidney Research and Clinical Practice

Korean Society of Nephrology (대한신장학회)
권호 표지

Antifibrotic Effect of BMP-7 in the Peritoneum and the Mechanism

Bone Morphogenic Protein-7의 복막섬유화 억제효과와 기전

Seo, Ji-Yeon;Ha, Hun-Joo;Yu, Mi-Ra;Kim, Jae-Ryong;Ahn, Myun-Whan;Lee, Hi-Bahl
서지연;하헌주;유미라;김재룡;안면환;이희발

  • Published : 20070100
⟨ Previous Next ⟩

Abstract

Purpose: Bone morphogenic protein (BMP)-7, a member of TGF-β1 superfamily, is an endogenous antifibrotic protein highly expressed in normal kidney. It is not known, however, whether human peritoneal mesothelial cells (HPMC) express BMP-7 or if BMP-7 protects against peritoneal fibrosis and by what mechanism. We examined the effect of BMP-7 overexpression in TGF-β1-induced epithelial-mesenchymal transition (EMT) of HPMC and in TGF-β1 signaling in HPMC to elucidate the mechanisms of antifibrotic effect of BMP-7. Methods: Growth arrested and synchronized HPMC were stimulated with 2 ng/mL of TGF-β1 to induce EMT. HPMC were transiently transfected with adenovirus-mediated human BMP-7 (AdBMP-7) or with GFP (AdGFP). EMT was defined as downregulation of E-cadherin and upregulation of α-smooth muscle actin (SMA). Results: HPMC constitutively expressed BMP-7 mRNA and protein. BMP-7 mRNA and protein expression were significantly inhibited by 50 mM D-glucose, 2x diluted commercial peritoneal dialysis solution, and 2 ng/ml of TGF-β1. Transfection of AdBMP-7 resulted in 2.5-fold increase in BMP-7 mRNA expression in HPMC. TGF-β1 significantly decreased E-cadherin and increased α-SMA expression in GFP transfected cells. BMP-7 overexpression effectively reversed TGF-β1-induced E- cadherin and α-SMA expression and significantly suppressed TGF-β1-induced phosphorylation of Smad2/3, ERK1/2, JNK, and p38 MAPK in HPMC as compared to GFP transfected cells. Conclusion: BMP-7 is an endogenous antifibrotic protein and downregulation of BMP-7 in HPMC by high glucose, PD solution, and TGF-β1 may permit the development of peritoneal fibrosis during long-term PD. Our data demonstrate that BMP-7 overexpression reverses TGF-β1-induced EMT of HPMC and consequent peritoneal fibrosis possibly through inhibition of Smad2/3 and MAPK phosphorylation.

목 적: Bone morphogenic protein (BMP)-7은 TGF-β superfamily에 속하는 내인성 항섬유화 단백질로 신장내에 대량 표현되어 있다. 그러나 사람 복막중피세포 (HPMC)가 BMP-7을 표현하는지, BMP-7이 복막섬유화를 억제하는지 또 그 기전이 무엇인지는 밝혀진바 없다. 본 연구에서는 HPMC에서 BMP-7의 과발현이 TGF-β1에 의한 상피세포-중간엽세포 이행 (EMT)과 TGF-β1 신호전달계에 미치는 영향을 관찰함으로써 BMP-7의 복막섬유화 억제 효과와 그 기전을 검색하였다. 방 법: 배양된 HPMC에 adenovirus vector를 매개로 human BMP-7 (AdBMP-7)과 GFP (AdGFP)를 transfection하였다. EMT는 2 ng/mL의 TGF-β1으로 유발하였고 E-cadherin의 감소와 α-smooth muscle actin (α- SMA)의 증가로 확인하였다. mRNA는 real time PCR로 단백은 Western blot으로 측정하였다. 결 과: HPMC는 기저 상태에서 BMP-7 mRNA와 단백을 표현하였다. 50 mM 포도당과 2배 희석한 상용 복막투석액 그리고 2 ng/mL TGF-β1은 HPMC의 BMP-7 mRNA 와 단백 표현을 의미 있게 억제하였다. AdBMP-7은 AdGFP에 비하여 BMP-7 mRNA 표현을 2.5배 증가시켰다. AdBMP-7은 TGF-β1에 의한 E-cadherin mRNA와 단백 감소 및 α-SMA mRNA와 단백 증가를 회복시키고 Smad2/3, ERK1/2, JNK, P38 MAPK의 인산화를 의미 있게 억제하였다. 결 론: HPMC에서 BMP-7은 내인성 항섬유화 단백으로 고포도당, 상용 복막투석액 그리고 TGF-β1은 모두 BMP- 7 표현을 억제함으로써 장기간의 복막투석 중 복막섬유화의 발생을 허용할 수 있음을 시사한다. BMP-7의 과발현은 TGF-β1에 의한 EMT 발생을 예방하는 동시에 Smad와 MAPK 인산화를 억제하여 Smad와 MAPK 활성억제가 HPMC의 EMT와 복막섬유화 억제에 관여할 수 있음을 시사한다.

Keywords

References

  1. Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth factors 22:233-241, 2004 https://doi.org/10.1080/08977190412331279890
  2. Urist MR: Bone: formation by autoinduction. Science 150:893-899, 1965 https://doi.org/10.1126/science.150.3698.893
  3. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534, 1988 https://doi.org/10.1126/science.242.4875.34
  4. Luyten FP, Cunningham NS, Ma S, Muthukumaran N, Hammonds RG, Nevins WB, Woods WI, Reddi AH: Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 264:13377-13380, 1989
  5. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167, 1992 https://doi.org/10.1002/mrd.1080320212
  6. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968, 2003 https://doi.org/10.1038/nm888
  7. Wang S, de Caestecker M, Kopp J, Mitu G, Lapage J, Hirschberg R: Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17:2504-2512, 2006
  8. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Mller GA, Kalluri R: Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285:F1060-F1067, 2003
  9. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J: Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279:F130-F143, 2000
  10. Wang SN, Lapage J, Hirschberg R: Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12:2392-2399, 2001
  11. Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA: Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63:2037-2049, 2003 https://doi.org/10.1046/j.1523-1755.2003.00035.x
  12. Wang S, Hirschberg R: Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 279:23200-23206, 2004 https://doi.org/10.1074/jbc.M311998200
  13. Williams JD, Craig KJ, Topley N, von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT:Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
  14. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046-1051, 2001
  15. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
  16. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001 https://doi.org/10.1016/S0002-9440(10)62533-3
  17. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002 https://doi.org/10.1172/JCI0215518
  18. Lan HY: Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12:25-29, 2003 https://doi.org/10.1097/00041552-200301000-00005
  19. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F, Lopez-Cabrera M: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348:403-413, 2003 https://doi.org/10.1056/NEJMoa020809
  20. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, Kelly MM: Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16:425-436, 2005 https://doi.org/10.1681/ASN.2004060436
  21. Aroeira LS, Aguilera A, Selgas R, Ramirez-Huesca M, Perez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sanchez-Tomero JA, Jimenez-Heffernan JA, Lopez-Cabrera M: Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 46:938-948, 2005 https://doi.org/10.1053/j.ajkd.2005.08.011
  22. Vargha R, Endemann M, Kratochwill K, Riesenhuber A, Wick N, Krachler AM, Malaga-Dieguez L, Aufricht C: Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 21:2943-2947, 2006 https://doi.org/10.1093/ndt/gfl355
  23. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB: Role of reactive oxygen species in TGFbeta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16:667-675, 2005 https://doi.org/10.1681/ASN.2004050425
  24. Bottinger EP, Bitzer M: TGF-beta signaling in renal disease. J Am Soc Nephrol 13:2600-2610, 2002 https://doi.org/10.1097/01.ASN.0000033611.79556.AE
  25. Hayashida T, deCaestecker M, Schnaper HW: Crosstalk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 17:1576-1578, 2003 https://doi.org/10.1096/fj.03-0037fje
  26. Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I: Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 95:918-931, 2005 https://doi.org/10.1002/jcb.20458
  27. Jang WS, Kim JR, Sohn WJ, Seo JS, Ahn MW, Jang YS, Kim HK, Kim JR: Osteoinduction using recombinant bone morphogenetic protein-7 gene. J Korean Orthop Assoc 39:598-606, 2004 https://doi.org/10.4055/jkoa.2004.39.6.598
  28. Ha H, Yu MR, Lee HB: High glucose-induced PKC activation mediates TGF-beta1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59:463-470, 2001 https://doi.org/10.1046/j.1523-1755.2001.059002463.x
  29. Lee HB, Yu MR, Song JS, Ha H: Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 65:1170-1179, 2004 https://doi.org/10.1111/j.1523-1755.2004.00491.x
  30. Ha H, Cha MK, Choi HN, Lee HB: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22:171-177, 2002
  31. Saika S, Ikeda K, Yamanaka O, Flanders KC, Ohnishi Y, Nakajima Y, Muragaki Y, Ooshima A: Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 290:C282-C289, 2006
  32. Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P: TGF-beta type 1 receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112:4557-4568, 1999
  33. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY: Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13:1464-1472, 2002 https://doi.org/10.1097/01.ASN.0000014252.37680.E4
  34. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A: TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16:1987-2002, 2005 https://doi.org/10.1091/mbc.E04-08-0658
  35. Hu MC, Wasserman D, Hartwig S, Rosenblum ND:p38 MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J Biol Chem 279:12051-12059, 2004 https://doi.org/10.1074/jbc.M310526200
  36. Lee MJ, Yang CW, Jin DC, Chang YS, Bang BK, Kim YS: Bone morphogenetic protein-7 inhibits constitutive and interleukin-1beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway. J Immunol 170:2557-2563, 2003 https://doi.org/10.4049/jimmunol.170.5.2557
  37. Hayes SA, Huang X, Kambhampati S, Platanias LC, Bergan RC: p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion. Oncogene 22:4841-4850, 2003 https://doi.org/10.1038/sj.onc.1206730
  38. Leivonen SK, Chantry A, Hakkinen L, Han J, Kahari VM: Smad3 mediates transforming growth factorbeta-induced collagenase-3 (matrix metalloproteinase -13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. J Biol Chem 277:46338-46346, 2002 https://doi.org/10.1074/jbc.M206535200